Androgenic alopecia. Androgenic alopecia
Conditions
Interventions
Intervention group: 10 injection sessions in superficial dermis of the scalp using 2 ml PLURYAL® Hair Density formulation, product of MD skin solution laboratories, LuxemburgEach prefilled syringe co
Sponsors
Tabesh Gostar Mehyad
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Male or female aged 18-50 years General health Male with mild-moderate androgenic alopecia (II-IV Norwood Hamilton Scale) Female with mild-moderate androgenic alopecia (I-II Ludwig Scale) Voluntary participation and signing written informed consent
Exclusion criteria
Exclusion criteria: Chronic active scalp disease other than hair loss Using any prescribed drug or OTC for hair loss within the past 3 months Documented sensitivity to formulation components Any severe weight loss or strict diet therapy during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair lost Changes, based on Global photographic review. Timepoint: First injection session (visit 0), week 6 and week 24. Method of measurement: One independent dermatologist will perform clinical assessments by scoring every photograph according to the Global photographic review scale . | — |
Secondary
| Measure | Time frame |
|---|---|
| Hair count changes. Timepoint: First injection session (visit 0), week 6 and week 24. Method of measurement: Trichoscopy By Fotofinder. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAniseh Samadi
Tehran University of Medical Sciences
Outcome results
None listed